{
    "clinical_study": {
        "@rank": "143109", 
        "arm_group": [
            {
                "arm_group_label": "Surgical treatment group", 
                "arm_group_type": "Experimental", 
                "description": "Unresectable mCRC patients who respond to chemotherapy will receive surgical resection of primary tumor."
            }, 
            {
                "arm_group_label": "Chemotherapy group", 
                "arm_group_type": "No Intervention", 
                "description": "Unresectable mCRC patients who were respond to chemotherapy will continue with chemotherapy."
            }
        ], 
        "brief_summary": {
            "textblock": "There is still no perfect treatment suggestion for patients with asymptomatic colorectal\n      cancer with unresectable metastatic disease. Whether patients can benefit from palliative\n      resection of primary tumor or not is still waiting for answer. The investigators hypothesis\n      that asymptomatic metastatic colorectal cancer patients who respond to chemotherapy will\n      benefit from primary tumor resection."
        }, 
        "brief_title": "Effectiveness Study of Resection of Primary Tumor in Stage IV Colorectal Cancer Patients", 
        "completion_date": {
            "#text": "July 2019", 
            "@type": "Anticipated"
        }, 
        "condition": "Colorectal Cancer Metastatic", 
        "condition_browse": {
            "mesh_term": [
                "Colorectal Neoplasms", 
                "Neoplasms"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  18 to 70 years old\n\n          -  both genders\n\n          -  ECOG:0-2 score\n\n          -  Pathological confirmed colon cancer or rectal cancer with at least 12 cm far away\n             from anal verge\n\n          -  CT,MRI,or PET-CT confirmed  metastasis\n\n          -  MDT confirmed unresectable metastasis lesion\n\n          -  No evidence of obstruction, bleeding, perforation\n\n          -  WBC\u22654.0\u00d7109/L\uff0cNeu \u22652.0\u00d7109/L\uff0cPLT\u2265100\u00d7109/L\n\n          -  No contraindication for chemotherapy\n\n          -  No evidence of other malignant tumor\n\n          -  Expected survival time > 6 months\n\n        Exclusion Criteria:\n\n          -  mCRC patients who did not respond to first line chemotherapy\n\n          -  Require surgical intervention during the primary tumor-related symptoms\n\n          -  Obvious coagulopathy\n\n          -  Severe heart, liver, kidney damage or other serious uncontrolled medical illness or\n             acute infection, cachexia\n\n          -  Severe organ damage after chemotherapy, surgery or unable to continue to systemic\n             chemotherapy\n\n          -  Pregnant or lactating women or women of childbearing age who refuse to accept\n             contraception.\n\n          -  Nearly three months participated in clinical trials of other persons.\n\n          -  Mental abnormalities"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "75 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "480", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "May 18, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02149784", 
            "org_study_id": "20140413"
        }, 
        "intervention": {
            "arm_group_label": "Surgical treatment group", 
            "description": "Surgical resection of primary tumor of mCRC patients who were respond to first line chemotherapy`", 
            "intervention_name": "Surgical resection of primary tumor", 
            "intervention_type": "Procedure"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Metastasis colorectal cancer", 
            "Chemotherapy", 
            "Resection of primary tumor"
        ], 
        "lastchanged_date": "May 25, 2014", 
        "location": {
            "contact": {
                "email": "chengong@sysucc.org.cn", 
                "last_name": "Gong Chen, Prof.", 
                "phone": "+86 20 87343584"
            }, 
            "facility": {
                "address": {
                    "city": "Guangzhou", 
                    "country": "China", 
                    "state": "Guangdong", 
                    "zip": "510060"
                }, 
                "name": "Sun Yat-Sen University Cancer Center"
            }, 
            "investigator": [
                {
                    "last_name": "Gong Chen, Prof.", 
                    "role": "Principal Investigator"
                }, 
                {
                    "last_name": "Rong-Xin Zhang, M.D.", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Yu-Hong Li, M.D.", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Ling-Hneg Kong, M.D.", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Zhi-qiang Wang, PhD.", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Xiao-Jun Wu, M.D.", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Zhi-Zhong Pan, M.D.", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Yan-Hong Deng, M.D.", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Hui Wang, M.D.", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Meng Qiu, M.D.", 
                    "role": "Sub-Investigator"
                }
            ], 
            "status": "Not yet recruiting"
        }, 
        "location_countries": {
            "country": "China"
        }, 
        "number_of_arms": "2", 
        "official_title": "Palliative Resection of Asymptomatic Primary Tumor Following Effective Induction Chemotherapy in Colorectal Cancer Patients With Unresectable Distant Metastasis: a Multi-center, Prospective, Randomized Controlled Study", 
        "overall_contact": {
            "email": "Chengong@sysucc.org.cn", 
            "last_name": "Gong Chen, Prof.", 
            "phone": "+86 20 87343584"
        }, 
        "overall_official": [
            {
                "affiliation": "Sun Yat-sen University", 
                "last_name": "Gong Chen, Prof.", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Sun Yat-sen University", 
                "last_name": "Zhi-zhong Pan, Prof.", 
                "role": "Study Chair"
            }, 
            {
                "affiliation": "Sun Yat-sen University", 
                "last_name": "De-Sen Wan, Prof.", 
                "role": "Study Director"
            }
        ], 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "China: Sun Yat-Sen University Cancer Center Ethic Committee", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "July 2016", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Overall survival", 
            "safety_issue": "No", 
            "time_frame": "3 years"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02149784"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Sun Yat-sen University", 
            "investigator_full_name": "Gong Chen", 
            "investigator_title": "Sun Yat-Sen University Cancer Center", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "measure": "Number of Participants with Adverse Events both in surgery group and chemotherapy group", 
            "safety_issue": "Yes", 
            "time_frame": "2 years"
        }, 
        "source": "Sun Yat-sen University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Sun Yat-sen University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "May 2014", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}